Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk

Several large statin trials and meta-analyses have demonstrated a reduction in low-density lipoprotein cholesterol (LDL-C) and cardiovascular morbidity and mortality. Some trials have also highlighted the significance of residual cardiovascular risk after treatment of LDL-C to target levels. This re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Rakesh K, Singh, Vibhuti N, Reddy, Hanumanth K
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754092/
https://www.ncbi.nlm.nih.gov/pubmed/19812691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754092/
https://www.ncbi.nlm.nih.gov/pubmed/19812691

Ejemplares similares